“`html
Leprosy: An Enduring Challenge and the Path to Elimination
Despite being a curable disease, leprosy continues to affect millions worldwide, frequently enough shrouded in stigma and misinformation. This article provides an updated overview of leprosy, its causes, global prevalence, treatment, and ongoing efforts towards its elimination, as of January 24, 2026.
What is Leprosy?
Leprosy, also known as Hansen’s disease, is a chronic infectious disease caused by the bacterium Mycobacterium leprae. It primarily affects the skin, peripheral nerves, upper respiratory tract, eyes, and testes. It isn’t highly contagious and requires prolonged, close contact with an untreated individual to spread. Transmission is believed to occur via droplets from the nose and mouth of infected persons.
Symptoms and Progression
Symptoms of leprosy can take years to develop, often appearing 5 to 20 years after infection. These typically include:
- Skin lesions: Discolored patches of skin, often with reduced sensation.
- Nerve damage: Weakness or numbness in the hands, feet, and arms, leading to muscle atrophy.
- Eye problems: Can lead to blindness if untreated.
- nasal congestion: Especially in more severe forms.
Without treatment, leprosy can cause permanent disability and disfigurement.
Global Prevalence and Impact
According to the World Health Organization (WHO), while the global prevalence of leprosy has considerably decreased over the past decades, it remains a public health concern in several countries. In 2022, over 140,000 new cases were reported globally. The countries with the highest numbers of new cases are India, Brazil, and Indonesia, representing over 80% of all new diagnoses.
Leprosy is closely linked to poverty, poor sanitation, and lack of access to healthcare. It disproportionately affects marginalized populations and those living in resource-limited settings.The WHO lists leprosy among the Neglected Tropical Diseases (NTDs), highlighting the need for increased attention and investment.
Diagnosis and Treatment
Leprosy is curable with multidrug therapy (MDT). MDT typically involves a combination of antibiotics – dapsone, rifampicin, and clofazimine – taken over a period of 6 to 12 months. MDT is provided free of charge by the WHO through national health programs in many endemic countries.